Debjani Grenier
Impact in
- Family Practice top 2%
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 8
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 2
-
- Breast Cancer Treatment Studies 4
- Co-authors
- Jonathan R. Walker (2 shared papers)Nazanin Fallah‐Rad (2 shared papers)Davinder S. Jassal (2 shared papers)Tielan Fang (2 shared papers)Sheena Bohonis (1 shared paper)Iain D. C. Kirkpatrick (1 shared paper)Marianne Krahn (1 shared paper)Anthony Wassef (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (3 papers)Journal of Clinical Oncology (2 papers)Cancer Treatment Reviews (1 paper)Cancer Prevention Research (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Debjani Grenier
18 papers receiving 1.8k citations
Debjani Grenier's Hit Papers
Peers
Comparison fields: 5 of 74
- Family Practice 77
- Oncology 865
- Cancer Research 460
- Geriatrics and Gerontology 77
- Cardiology and Cardiovascular Medicine 492
Countries citing papers authored by Debjani Grenier
This map shows the geographic impact of Debjani Grenier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debjani Grenier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debjani Grenier more than expected).
Fields of papers citing papers by Debjani Grenier
This network shows the impact of papers produced by Debjani Grenier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debjani Grenier. The network helps show where Debjani Grenier may publish in the future.
Co-authors
The 25 scholars most cited alongside Debjani Grenier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 2 | 2009 | 436 | |
| 3 | 2011 | 393 | |
| 4 | 2008 | 121 | |
| 5 | 2010 | 111 | |
| 6 | 2004 | 108 | |
| 7 | 2019 | 55 | |
| 8 | 2012 | 30 | |
| 9 | 2010 | 27 | |
| 10 | 2018 | 18 | |
| 11 | 2016 | 18 | |
| 12 | 2022 | 16 | |
| 13 | 2020 | 13 | |
| 14 | 2021 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2011 | 9 | |
| 17 | 2020 | 5 | |
| 18 | 2016 | 1 | |
| 19 | 2014 | 0 |
About Debjani Grenier
Debjani Grenier is a scholar working on Oncology, Cancer Research, Genetics, Family Practice and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), BRCA gene mutations in cancer (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Patient-Provider Communication in Healthcare (2 papers) and Bone health and osteoporosis research (1 paper). The work is most often cited by research in Family Practice (77 citations), Oncology (865 citations), Cancer Research (460 citations), Geriatrics and Gerontology (77 citations) and Cardiology and Cardiovascular Medicine (492 citations). Debjani Grenier has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Jonathan R. Walker, Nazanin Fallah‐Rad, Davinder S. Jassal, Tielan Fang, Sheena Bohonis, Iain D. C. Kirkpatrick, Marianne Krahn, Anthony Wassef, Matthew Lytwyn and Pawan K. Singal. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, Cancer Treatment Reviews, Cancer Prevention Research and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.